Anna Borodovsky
Company: Alnylam Pharmaceuticals
Job title: Vice President & Director - Research
Seminars:
Harnessing RNAi for the Development of Complement Therapeutics 1:30 pm
Mechanism and properties of Alynlam’s RNA interference drugs Applications of Cemdisiran, a C5 targeting siRNA Exploring RNAi for other complement pathway targetsRead more
day: Conference Day Two